Back to today’s briefing

Story perspectives

Rep. Auchincloss Challenges FDA's Controversial Drug Review Program

2/4/2026

38 8 Full Breakdown

Summary

Story summary

Rep. Jake Auchincloss (D-Mass.) questions the FDA's National Priority Voucher program, which expedites drug reviews.
He says Congress did not approve the program and the FDA's legal office was not consulted.
He notes a lack of transparency in financial disclosures for senior FDA officials involved, which he says could create conflicts.
He demands that the FDA affirm or refute his findings, noting that inquiries from other lawmakers went unanswered.

1 of 1

Story summary

Rep. Jake Auchincloss (D-Mass.) questions the FDA's National Priority Voucher program, which expedites drug reviews.
He says Congress did not approve the program and the FDA's legal office was not consulted.
He notes a lack of transparency in financial disclosures for senior FDA officials involved, which he says could create conflicts.
He demands that the FDA affirm or refute his findings, noting that inquiries from other lawmakers went unanswered.